Financial Wire

EMEA Natural Gas Update: Futures Rise Despite Reports of Ceasefire Extension Between the US, Iran

-- European natural gas futures were up on Thursday, amid reports of the US and Iran considering an extension to the current ceasefire by two more weeks, to allow more time to negotiate a peace agreement.

The front-month Dutch TTF contract rose 1.96% to 42.21 euros ($49.72) per megawatt-hour, while UK NBP futures rose 1.91% to 105.65 British pence ($1.42) per therm.

The ceasefire, which was set to end on the coming Tuesday, could be extended further, as negotiators on both sides plan to hold technical talks, which include the reopening of the Strait of Hormuz and Iran's nuclear enrichment, according to a Bloomberg report, citing a person familiar with the matter.

Meanwhile, the US Central Command has released audio recordings of US Naval vessels enforcing the blockade against Iran, with commercial ships being threatened with "interdiction and seizure" for transiting to and from Iranian ports.

Transit through the Strait, however, inched higher, with 19 vessels passing through it over the past 24 hours, according to the Hormuz Strait Monitor.

This is still significantly below the typical daily average of 138 ships per day, according to the UK's Joint Maritime Information Center.

As such, Daniel Hynes, a senior commodity strategist at ANZ, noted that traders remained mindful of the fact that "supplies remain severely constrained" with the Strait still being effectively closed, despite growing optimism regarding a potential peace deal.

He attributed the recent pullback in energy prices to the unwinding of "large net long positions recently accumulated by investment funds."

European gas inventories continued to see net injections, with storage still lower at 29.55% of capacity, compared to 35.97% during the corresponding period a year ago, according to Gas Infrastructure Europe.

相關文章

Asia

河北常山生化製藥有限公司的血液稀釋注射劑獲吉爾吉斯斯坦批准

根據週四提交深圳證券交易所的披露文件顯示,吉爾吉斯斯坦藥品監管機構已批准河北常山生化藥業(深交所代碼:300255)的肝素鈉注射液上市。 文件指出,該藥物用於治療血栓或栓塞性疾病,具有抗凝血作用,可預防血栓形成。

$SHE:300255
Mining & Metals

鈾礦特許權使用費在盤前交易上漲6.6%,此前該公司同意以19億美元收購Sweetwater Royalties。

Uranium Royalty (URC.TO, UROY) 週四宣布,已同意以19億美元(含債務)的價格從Orion Resource Partners和安大略省教師退休金計劃管理的基金手中收購Sweetwater Royalties,受此消息提振,該公司股價在納斯達克盤前交易中上漲6.6%。 這家總部位於溫哥華的公司表示,將把註冊地遷至德拉瓦州以完成交易。 Uranium Royalty將保留原有名稱,並將此變更稱為「新URC」。現有股東將以1:1的比例獲得新URC的股份,而Sweetwater的股東將獲得價值8.13億美元的新公司股份(每股作價3.64美元)和3.3億美元現金,同時新URC也將承擔Sweetwater的6.25億美元債務。 這項交易將造就美國第二大土地所有者(不包括房地產投資信託基金),以及懷俄明州最大的土地所有者。交易完成後,該公司將控制85萬英畝的地表權和450萬英畝的礦產開採權,進一步擴大其在薩斯喀徹溫省阿薩巴斯卡盆地、懷俄明州和納米比亞的現有礦產資源組合。該公司表示,這筆交易也將使鈾礦資源公司(Uranium Royalty)成為美國最大的上市非貴金屬礦產資源公司。 此次收購也將使該公司獲得Sweetwater在懷俄明州的純鹼礦產資源組合。 Sweetwater在懷俄明州已知鈉租賃區擁有20萬英畝的土地,用於開採這種用於生產玻璃、化學品和其他工業產品的工業礦物。 「我們歡迎這項變革性的合併,它將加速來自位於頂級司法管轄區懷俄明州的具有競爭力、可靠性高且壽命長的資產的近期現金流。我們對懷俄明州有著深厚的感情和熟悉程度。更重要的是,它為我們提供了強大的財務基礎,使我們能夠在核能歷史性增長時期充分實現並擴大我們在鈾礦領域的業務。 該公司表示,將以現有現金和4,000萬美元的認購憑證為此交易提供資金。 鈾礦特許權使用費公司(Uranium Royalty)的股票在盤前交易中上漲0.23美元,至4.15美元。週三在多倫多證券交易所,該股收盤上漲0.25加元,至5.40加元。

$URC.TO$UROY
Asia

韓森製藥的肺癌藥物在中國獲得突破性療法認定

根據週四在香港交易所發布的公告顯示,韓森製藥(HKG:3692)的注射用藥物HS-20093(與阿德布雷利單抗聯合使用)已獲得中國國家藥品監督管理局批准,成為突破性療法指定藥物。 該藥物獲準用於治療局部晚期或轉移性非小細胞肺癌。

$HKG:3692